Natus Medical Inc Revenue Growth Rates (NTUS), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Natus Medical Inc  (NASDAQ: NTUS)
 

NTUS's Revenue Growth by Quarter and Year

Natus Medical Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NTUS Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 119.79
FY 119.79

NTUSs Annual Revenue
Natus Medical Inc's Revenue in the fiscal year 2021 $ 473.44 millions
Natus Medical Inc's Revenue in the fiscal year 2020 $ 415.68 millions
Natus Medical Inc's Revenue in the fiscal year 2019 $ 495.18 millions
Natus Medical Inc's Revenue in the fiscal year 2018 $ 530.89 millions
Natus Medical Inc's Revenue in the fiscal year 2017 $ 500.97 millions




NTUS Revenue first quarter 2022 Y/Y Growth Comment
Natus Medical Inc reported Revenue growth of 4.23% year on year in the first quarter 2022, to $ 119.79 millions, this is lower than Natus Medical Inc's recent average Revenue growth of 9.7%.

Looking into first quarter 2022 results within Medical Equipment & Supplies industry 126 other companies have achieved higher Revenue growth. While Natus Medical Inc' s Revenue increase of 4.23% ranks overall at the positon no. 3053 in the first quarter 2022.


NTUS Revenue ( Y/Y Growth %) 2022
 2021 2020 2019
4th Quarter December - 8.37 % -9.66 % 0.59 %
3rd Quarter September - 10.78 % -16.73 % -4 %
2nd Quarter June - 36.8 % -32.47 % -4.49 %
1st Quarter March 4.23 % 5.07 % -16.27 % 6.52 %
FY   - 13.9 % -18.66 % -

Financial Statements
Natus Medical Inc's first quarter 2022 Revenue $ 119.79 millions NTUS's Income Statement
Natus Medical Inc's first quarter 2021 Revenue $ 114.93 millions Quarterly NTUS's Income Statement


NTUS Revenue (Quarter on Quarter Growth %)

 2022
 2021 2020 2019
4th Quarter December - 12.98 % 15.49 % 6.45 %
3rd Quarter September - -1.81 % 21.26 % -1.66 %
2nd Quarter June - 0.91 % -22.49 % -3.9 %
1st Quarter March -6.89 % -3.19 % -16.77 % -0.01 %
FY (Year on Year)   - 13.9 % -18.66 % -


Back to NTUS Growth rate Comparisons >> Back to NTUS Growth rate Comparisons >>


Revenue first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #127
Healthcare Sector #466
Overall #3053

Revenue Y/Y Growth Statistics
High Average Low
57.24 % 9.7 % -32.47 %
(Mar 31 2013)   (Jun 30 2020)
Revenue first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #127
Healthcare Sector #466
Overall #3053
Revenue Y/Y Growth Statistics
High Average Low
57.24 % 9.7 % -32.47 %
(Mar 31 2013)   (Jun 30 2020)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Natus Medical Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
32.31 % 2.28 % -22.49 %
(Sep 30 2012)  


NTUS's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2022 Natus Medical Inc disclosed decline in Revenue from the fourth quarter by -6.89% to $ 119.79 millions, from $ 128.66 millions achived in the previous reporting period.

But that's not important problem, as Natus Medical Inc's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 105 other companies have achieved higher Revenue quarter on quarter growth. While Natus Medical Inc's Revenue growth quarter on quarter, overall rank is 2643.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #106
Healthcare Sector #395
Overall #2643
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #106
Healthcare Sector #395
Overall #2643
Revenue Q/Q Growth Statistics
High Average Low
32.31 % 2.28 % -22.49 %
(Sep 30 2012)  


NTUS's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2022 Natus Medical Inc disclosed decline in Revenue from the fourth quarter by -6.89% to $ 119.79 millions, from $ 128.66 millions achived in the previous reporting period.

But that's not important problem, as Natus Medical Inc's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 105 other companies have achieved higher Revenue quarter on quarter growth. While Natus Medical Inc's Revenue growth quarter on quarter, overall rank is 2643.


Natus Medical Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2022)		 12 Months Ending
(Dec 31 2021)		 12 Months Ending
(Sep 30 2021)		 12 Months Ending
(Jun 30 2021)		 12 Months Ending
(Mar 31 2021)
Cumulative Revenue 12 Months Ending $ 478.30 $ 473.44 $ 463.50 $ 452.43 $ 421.23
Y / Y Revenue Growth (TTM) 13.55 % 13.89 % 8.2 % 0.75 % -14 %
Year on Year Revenue Growth Overall Ranking # 3410 # 1516 # 1375 # 2997 # 2601
Seqeuential Revenue Change (TTM) 1.03 % 2.14 % 2.45 % 7.41 % 1.33 %
Seq. Revenue Growth (TTM) Overall Ranking # 3026 # 1063 # 553 # 2460 # 3105


Cumulative Revenue growth Comment
Assuming the Natus Medical Inc's fiscal year would have ended in Mar 31 2022, Natus Medical Inc would have reprted above average annual Revenue increase of 13.55% year on year, of $ 478 millions.
This marks a slow-down of the companys growth trends and from the 13.89% rise in Dec 31 2021.

In the Healthcare sector 456 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1516 to 3410.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 136
Healthcare Sector # 457
Overall # 3410

Revenue TTM Y/Y Growth Statistics
High Average Low
31.18 %
 5.65 %
-19.16 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 136
Sector # 410
S&P 500 # 3026
Cumulative Revenue growth Comment
Assuming the Natus Medical Inc's fiscal year would have ended in Mar 31 2022, Natus Medical Inc would have reprted above average annual Revenue increase of 13.55% year on year, of $ 478 millions.
This marks a slow-down of the companys growth trends and from the 13.89% rise in Dec 31 2021.

In the Healthcare sector 456 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1516 to 3410.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 136
Healthcare Sector # 457
Overall # 3410

Revenue TTM Y/Y Growth Statistics
High Average Low
31.18 %
5.65 %
-19.16 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 136
Sector # 410
S&P 500 # 3026




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NTUS's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2022
West Pharmaceutical Services Inc 7.35%$ 7.351 millions
Bruker Corporation7.27%$ 7.265 millions
Nuvasive Inc7.19%$ 7.194 millions
Heska Corporation7.10%$ 7.102 millions
Anika Therapeutics Inc 7.00%$ 7.002 millions
Sigilon Therapeutics Inc 7.00%$ 6.998 millions
Hca Healthcare Inc 6.93%$ 6.926 millions
Msa Safety Inc6.92%$ 6.924 millions
Biomarin Pharmaceutical Inc6.86%$ 6.857 millions
Neurometrix Inc 6.82%$ 6.816 millions
Harvard Bioscience Inc 6.63%$ 6.629 millions
Sonoma Pharmaceuticals Inc 6.54%$ 6.537 millions
Acadia Healthcare Company Inc 6.42%$ 6.417 millions
Fonar Corporation6.41%$ 6.414 millions
Semler Scientific inc 6.32%$ 6.319 millions
Radnet Inc 6.28%$ 6.282 millions
Adm Tronics Unlimited Inc 6.24%$ 6.241 millions
Zoetis Inc 6.15%$ 6.146 millions
Vycor Medical Inc 6.11%$ 6.115 millions
Alimera Sciences Inc6.10%$ 6.100 millions
Cumberland Pharmaceuticals Inc 6.05%$ 6.054 millions
Amgen Inc 5.71%$ 5.711 millions
Vivos Therapeutics Inc 5.68%$ 5.684 millions
Interpace Biosciences Inc 5.53%$ 5.532 millions
Innoviva Inc 5.31%$ 5.310 millions
Bristol myers Squibb Company5.19%$ 5.193 millions
Mesoblast Limited5.01%$ 5.013 millions
Nektar Therapeutics4.97%$ 4.969 millions
Healthcare Services Group Inc 4.67%$ 4.674 millions
Iqvia Holdings Inc 4.66%$ 4.664 millions


About Natus Medical Inc Revenue Growth Rates (NTUS), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Natus Medical Inc (CIK 878526).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0000878526-22-000034
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Natus Medical Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.